💊
Pazenir
paclitaxel
Neoplazii ale sânului
✅ Autorizat
Generic
✅
Nu există alerte active
Acest medicament nu are penurii în curs, scrisori de siguranță sau retrageri de pe piață.
La ce se utilizează
Pazenir monotherapy is indicated for the treatment of metastatic breast cancer in adult patients who have failed first-line treatment for metastatic disease and for whom standard, anthracycline containing therapy is not indicated. Pazenir in combination with carboplatin is indicated for the first-line treatment of non-small cell lung cancer in adult patients who are not candidates for potentially curative surgery and/or radiation therapy.
⚠️ Siguranță a pacientului
No
📚 Alerte anterioare (2)
Pagina oficială EMA
https://www.ema.europa.eu/en/medicines/human/EPAR/pazenir